Tepmetko Prices, Coupons, Copay Cards & Patient Assistance
Tepmetko (tepotinib) is a member of the multikinase inhibitors drug class and is commonly used for Non Small Cell Lung Cancer.
The cost for Tepmetko 225 mg oral tablet is around $12,868 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Tepmetko is available as a brand name drug only, a generic version is not yet available. View generic Tepmetko availability for more details.
Tepmetko prices
Oral Tablet
225 mg
Tepmetko oral tablet
from $12,868.21
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 (3 x 10 each) | $428.94 | $12,868.21 |
60 (6 x 10 each) | $428.78 | $25,726.92 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Tepmetko Coupons, Copay Cards and Rebates
Tepmetko offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Tepmetko ONC Co-Pay Assistance Program
Eligible commercially insured patients may pay as little as $0 per prescription; maximum savings of $15,000 per year; for additional information contact the program at 844-662-3631.
- Applies to:
- Tepmetko
- Number of uses:
- Per prescription per year
- Expires
- December 31, 2024
Form more information phone: 844-662-3631 or Visit website
Tepmetko Bridge Program
Eligible commercially insured patients who are experiencing an insurance delay of at least 5 business days may receive their initial prescription for FREE.
- Applies to:
- Tepmetko
- Number of uses:
- Temporary Assistance
Form more information phone: 844-662-3631 or Visit website
Patient Assistance & Copay Programs for Tepmetko
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Tepmetko (tepotinib) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: CoverOne Program: Tepmetko
Eligibility requirements:- Contact program for details.
- Not disclosed
- Medically Necessary as determined by a Doctor
- The patient must also be residing in the US.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Tepmetko (tepotinib) Tablet
More information please phone: 844-662-3631 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Tepmetko (tepotinib)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español